Biologic Target

A biologic target, also known as a drug target or molecular target, is a specific molecule in the body, typically a protein, that is intrinsically involved in a particular disease process and can be acted upon by a drug to produce a therapeutic effect [2, 9]. These targets include receptors, enzymes, ion channels, and transporters, as well as nucleic acids in some cases [3, 6]. The process of target identification and validation is a critical first step in drug discovery, involving the demonstration that modulating the target's activity will lead to a desired clinical outcome [2, 10]. Modern pharmacology relies on the rational design of therapies, such as small molecules or monoclonal antibodies, to interact specifically with these targets while minimizing off-target effects [9, 11]. Biologic targets are central to the concept of precision medicine, where treatments are tailored based on the presence or activity of specific molecular markers in a patient [9]. Successful drug development requires a deep understanding of the target's structure, function, and role in both healthy and diseased states to ensure efficacy and safety [2].

Other names

Drug targetMolecular targetTherapeutic targetBiological target

The mechanism of action involves the specific binding of a drug to the biologic target, leading to the modulation of its physiological function, such as inhibition of enzymatic activity, blockade of receptor signaling, or alteration of ion transport [2, 9, 10].